AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …

The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The most common side …

Mar 5, 2024 · Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine (Ingrezza), tetrabenazine (Xenazine), amantadine, vitamin B6 (pyridoxine) and pyridoxal …

Nov 12, 2025 · Austedo standard and XR tablets are currently indicated for adults for the treatment of chorea in Huntington disease and tardive dyskinesia. Austedo is the first VMAT2 inhibitor approved …

Nov 10, 2025 · Discover what is the medication for tardive dyskinesia Austedo (deutetrabenazine), its mechanism of action as a VMAT2 inhibitor, side effects, and how it treats involuntary movements.

4 days ago · Tardive dyskinesia is a movement disorder caused most often by long-term use of certain medicines that block dopamine. If you have tardive dyskinesia , you will notice repeated, involuntary …

Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.

Dosage/Administration The dose of deutetrabenazine (Austedo) is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. The package insert …

Sep 21, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more